- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00456339
Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children
September 4, 2013 updated by: University of Chicago
The Effect of a Combination of Systemic Steroids and Antibiotics on Obstructive Sleep Apnea Syndrome in Children
The purpose of this study is to investigate the effect of treatment with a steroid and antibiotic on the size of the tonsils and symptoms of children with OSAS.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
We will enroll children between 18 months and 12 years of age with mild sleep apnea and treat them with 5 days of prednisolone and 10 days of amoxicillin/clavulanate.
We will obtain a questionnaire pre and post treatment and ask the parents to tell us if they think the child has improved enough after treatment to forego surgery.
If not, they will undergo an adenotonsillectomy to relieve their sleep apnea and if yes, we will repeat the sleep study to make sure that the apnea has resolved.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Polysomnogram results showing mild obstructive sleep apnea.
Exclusion Criteria:
- Significant medical problems
- Chronic medication intake (except bronchodilators and inhaled steroids)
- Allergy to penicillin or its derivatives.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sleep apnea questionnaire
Time Frame: 1-2 weeks post treatment
|
1-2 weeks post treatment
|
Size of tonsils
Time Frame: before and after treatment
|
before and after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Fuad M Baroody, MD, University of Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2006
Primary Completion (Actual)
July 1, 2007
Study Completion (Actual)
July 1, 2007
Study Registration Dates
First Submitted
April 3, 2007
First Submitted That Met QC Criteria
April 3, 2007
First Posted (Estimate)
April 4, 2007
Study Record Updates
Last Update Posted (Estimate)
September 5, 2013
Last Update Submitted That Met QC Criteria
September 4, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Disease
- Signs and Symptoms, Respiratory
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Syndrome
- Apnea
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Anti-Bacterial Agents
- beta-Lactamase Inhibitors
- Prednisolone
- Amoxicillin
- Clavulanic Acid
- Clavulanic Acids
- Amoxicillin-Potassium Clavulanate Combination
Other Study ID Numbers
- 001 (14397A)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea Syndrome
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
University Hospital, GrenobleTerminatedChronic Obstructive Pulmonary Disease (COPD) | Obstructive Sleep Apnea Syndrome (OSAS)France
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
-
Karolinska University HospitalCompletedObstructive Sleep Apnea Syndrome in ChildrenSweden
-
University of Alabama at BirminghamTerminatedObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)United States
-
Sakarya UniversityUnknown
-
Karolinska University HospitalKarolinska InstitutetCompletedObstructive Sleep Apnea SyndromeSweden
-
Haute Ecole de Santé VaudUnknownObstructive Sleep Apnea SyndromeSwitzerland
-
Tyco Healthcare GroupUnknown
Clinical Trials on Prednisolone and amoxicillin/clavulanate
-
Alejandro HobermanNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedAcute Otitis MediaUnited States
-
Albany Medical CollegeCompleted
-
Nantes University HospitalUnknown
-
Spero TherapeuticsIqvia Pty LtdCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityUnknownProtracted Bacterial Bronchitis
-
University Hospital of FerraraCompletedDevice Related Infection
-
Chang Gung Memorial HospitalCompletedThyroid NoduleTaiwan
-
University of OuluCompletedOtitis Media, SuppurativeFinland
-
Seoul National University HospitalUnknownSurgical Wound Infection | Thyroid NoduleKorea, Republic of